Who
Tyler Paz Korman
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, eXoZymes.
In numbers
- Trades disclosed
- 11
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $31K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 16 Jun 2025
- Last trade
- 19 Aug 2026
- Last filed
- 25 Aug 2026
Companies traded
Activity over time
1 Apr – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Aug 2026filed 25 Aug 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Code M | —32,964 | filing |
| 19 Aug 2026filed 25 Aug 2026 | EXOZ eXoZymesoption or derivative · Biotechnology | SEC FORM 4 Code M | —32,964 at $0.00 | filing |
| 19 Aug 2026filed 25 Aug 2026 | EXOZ eXoZymesoption or derivative · Biotechnology | SEC FORM 4 Code M | —32,964 at $0.00 | filing |
| 19 Aug 2026filed 25 Aug 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Code M | —32,964 | filing |
| 9 Apr 2026filed 10 Apr 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Sold | $7,894750 at $10.53 | filing |
| 9 Apr 2026filed 10 Apr 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Sold | $7,898750 at $10.53 | filing |
| 8 Apr 2026filed 10 Apr 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Sold | $7,530750 at $10.04 | filing |
| 8 Apr 2026filed 10 Apr 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Sold | $7,530750 at $10.04 | filing |
| 1 Apr 2026filed 8 Apr 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Code A | $45K5,332 at $8.44 | filing |
| 1 Apr 2026filed 8 Apr 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Code A | $45K5,332 at $8.44 | filing |
| 16 Jun 2025filed 17 Jun 2025 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Code A | $37K2,990 at $12.54 | filing |
News
Comparing eXoZymes (NASDAQ:EXOZ) and Allogene Therapeutics (NASDAQ:ALLO)EXOZ · dailypolitical.com · 16 Oct 2026
0 headlines in the last 90 days name Tyler Paz Korman; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.